These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18703951)

  • 21. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.
    DuBiner H; Cooke D; Dirks M; Stewart WC; VanDenburgh AM; Felix C
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S353-60. PubMed ID: 11434938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of topical prostaglandin therapy on corneal layers thickness in primary open-angle glaucoma patients using anterior segment optical coherence tomography.
    Eraslan N; Celikay O
    Int Ophthalmol; 2023 Sep; 43(9):3175-3184. PubMed ID: 37067694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
    Aptel F; Cucherat M; Denis P
    J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.
    Mesci C; Aydin N; Erbil HH
    J Glaucoma; 2011 Oct; 20(8):477-81. PubMed ID: 21048508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
    Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of central corneal thickness on response to topical prostaglandin analogue therapy.
    Birt CM; Buys YM; Kiss A; Trope GE;
    Can J Ophthalmol; 2012 Feb; 47(1):51-4. PubMed ID: 22333852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
    Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
    Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.
    Dirks MS; Noecker RJ; Earl M; Roh S; Silverstein SM; Williams RD
    Adv Ther; 2006; 23(3):385-94. PubMed ID: 16912020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes.
    Bafa M; Georgopoulos G; Mihas C; Stavrakas P; Papaconstantinou D; Vergados I
    Acta Ophthalmol; 2011 Aug; 89(5):448-51. PubMed ID: 19878123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Noecker RS; Dirks MS; Choplin N;
    Am J Ophthalmol; 2004 Jan; 137(1):210-1; author reply 211-2. PubMed ID: 14700685
    [No Abstract]   [Full Text] [Related]  

  • 33. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
    Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
    Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study.
    Fechtner R; Mansberger S; Branch J; Mulaney J; Ziebell S; Lopez K; Hubatsch D
    Am J Ophthalmol; 2024 Aug; 264():66-74. PubMed ID: 38499140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes.
    Tsikripis P; Papaconstantinou D; Koutsandrea C; Apostolopoulos M; Georgalas I
    Drug Des Devel Ther; 2013; 7():1149-56. PubMed ID: 24115838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
    Crichton AC; Vold S; Williams JM; Hollander DA
    Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol?
    Soto J; Diaz S
    Eur J Ophthalmol; 2010; 20(1):246-7; author reply 247-8. PubMed ID: 20047180
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
    Konstas AG; Holló G; Irkec M; Tsironi S; Durukan I; Goldenfeld M; Melamed S
    Br J Ophthalmol; 2007 Jun; 91(6):757-60. PubMed ID: 17124241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
    Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.